Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunoprecise Antibodies Ltd
(NQ:
IPA
)
1.290
+0.030 (+2.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Immunoprecise Antibodies Ltd
< Previous
1
2
3
4
Next >
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
June 22, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
Histopathology Preclinical Data from ImmunoPrecise’s Polytope™ Program Confirms Lung Inflammation Reduction
June 17, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
Preclinical Data from ImmunoPrecise’s Drug Pipeline to be Presented During the BIO International Partnering Event
June 15, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche
June 02, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Names Dr. Dion Neame to Strategic Advisory Board
May 25, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program’s Path Toward IND Filing
May 20, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
ImmunoPrecise Selects LifeSci Advisors as Investor Relations Agent of Record
April 21, 2021
From
ImmunoPrecise Antibodies Ltd.
Via
Business Wire
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer’s Disease
April 08, 2021
From
ImmunoPrecise Antibodies
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.